BERBERIAN LANCE 4

What Happened

• Lance Berberian, a director of Privia Health Group, Inc. (PRVA), was granted 8,463 restricted stock units (RSUs) on May 20, 2026. The award was reported as an A (award/grant) transaction at $0.00 per share (no cash paid at grant).

Key Details

• Transaction date and price: May 20, 2026 — 8,463 RSUs @ $0.00.
• Total immediate cash value reported: $0 (award of RSUs, not a purchase).
• Shares owned after transaction: Not stated in the provided filing.
• Footnote: The RSUs vest on the earlier of (i) the day immediately preceding the Company’s 2027 annual meeting of stockholders or (ii) the first anniversary of the grant (May 20, 2027 if earlier).
• Filing timeliness: Form 4 filed May 22, 2026; appears to be timely (filed within required reporting window).

Context

• RSUs are compensation awards that convert into common shares only upon vesting; they do not represent immediately tradable stock. Director grants like this are common as part of board compensation and do not by themselves indicate a buy or sell signal.